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Hiccups are a benign physiological feature affecting almost everyone at one time or another. They tend to be short-lived and 
do not affect quality of life; however, there are various pathologies that may present with long-lasting hiccups. These are 
grouped into 3 categories according to their duration: acute, persistent and intractable or protracted hiccups. Intractable hic-
cups last longer than 2 months and are usually associated with more severe conditions. The association between intractable 
hiccups and reflux disease has not been previously documented by objective methods. This report describes the case of a 
23-year-old female who presented with protracted hiccups; all other organic pathologies were ruled out, and endoscopy and 
conventional pH-metry confirmed a diagnosis of non-erosive reflux disease as the unique cause.
(J Neurogastroenterol Motil 2010;16:424-427)
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Introduction
Hiccups are a benign physiological feature that most people 
experience at some point in their lives. They tend to be short- 
lived and do not significantly affect quality of life. Although hic-
cups are an involuntary and self-limited symptom, they can be-
come an exhausting manifestation of disease. There are various 
pathologies that may present with long-lasting hiccups.
1
Hiccups are produced by a spontaneous, sudden and fast 
contraction of the diaphragm and accessory muscles of inspira-
tion, followed by the sudden inhibition of these muscles, which 
produces an abrupt closure of the glottis and interrupts the air 
column to produce the typical sound. The neurological mecha-
nisms of hiccups are integrated by an afferent and efferent path-
way mediated by the phrenic nerve, the sympathetic chain and the 
vagus nerve. The pathway involves a central neurological relief in 
the hypothalamus and an efferent pathway that reaches the dia-
phragm, glottis and intercostal muscles via the phrenic nerve.
2,3
Hiccups are grouped into 3 categories according to their 
duration. Acute hiccups, which last less than 48 hours, are mainly 
associated with several gastric alterations, such as gastric dis-
tension, gastritis, tobacco use or alcohol ingestion. Persistent hic-
cups, in contrast, have a duration between 48 hours and less than 
2 months. Finally, intractable or protracted hiccups, which last 
longer than 2 months, are called “singultus.” Singultus may re-Non-Erosive Reflux Manifested by Hiccups
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Figure 1. Correlation of hiccups (green vertical lines) with pH 
decreases (drops in the pH line).
Table 1. Correlation of the Clinical Presentation and Treatment
Period (mo) Anti-reflux treatment Hiccups/day
  1-10
a None 16
11-12 Esomeprazole/metoclopramide   8
12-14 Plus domperidone/chlorpromazine   3
14-15 Omeprazole/metoclopramide/domperidone 4-5
15-17 Omeprazole/domperidone   8
   18 Rabeprazole/domperidone   0.42
   19
b None 8-9
20-24 Omeprazole/domperidone 4-5
aConventional pH-metry test monitoring, 
bIntraluminal impedance pH-metry 
monitoring.
Figure 2. Representative portion of the esophageal impedance pH 
recording without the use of proton pump inhibitors showing an 
association between the hiccup episodes (yellow vertical lines) and the 
acid events (drops in the pH line).
sult from intestinal or CNS cancer, metabolic disorders, drugs, 
anesthesia, myocardial infarction, demyelination or other condi-
tions.
3-6
In general, most of the causes of hiccups originate in the di-
gestive tract, and the CNS is also often involved. The association 
between hiccups and reflux disease has not been previously docu-
mented by objective methods. The aim of the present report was 
to describe a case where the presence of gastroesophageal reflux 
disease was diagnosed based on the presentation of hiccups and 
supported by conventional and impedance pH-metry.
Case Report
This case involves a 23-year-old female with no history of al-
coholism, smoking or allergies, who was referred for ureter-
opyelic stenosis, which was diagnosed at 16 years old, and Ray-
naud’s disease, which was diagnosed at 17 years old.
Her symptoms first began in January, 2 years prior to pre-
sentation, with a sudden onset of hiccups, which evolved over 10 
months. The first stage of the work-up involved several medical 
examinations, including a computed tomography scan of her 
head, neck, chest and abdomen as well as complete blood count, 
blood chemistry, urine test, anti-nuclear antibodies, anti-DNA 
antibodies, anti-Smith, anti-histone, anti-centromere, anti-Ro 
and anti-La tests, which were all negative.
A gastroenterology evaluation was initiated and included an 
esophago-gastro-duodenoscopy and pH-metry. The esophago- 
gastro-duodenoscopy revealed a normal esophagus but showed 
petechial gastritis in the body and fundus of the stomach. A high 
exposition and an elevated number of reflux events were docu-
mented by conventional pH-metry: a total of 7.8% of the time at 
pH ＜ 4 and 271 reflux events (Fig. 1). A total of 16 hiccup 
events occurred in 24 hours of the test, 12 of which coincided 
with reflux. The symptom-association probability (SAP) with re-
spect to the hiccups was 97.4%, and the symptom index (SI) was 
45.5%. In view of these findings, the hypothesis that the hiccups 
were a manifestation of atypical gastroesophageal reflux was jus-
tified.
Treatment was started with various proton pump inhibitors 
(PPIs), H2-inhibitors, prokinetics and a decrease of approx-
imately 50% in the number of hiccup events was achieved.
After 2 months, chlorpromazine was added to finalize control 
of the hiccups, and this resulted in a decrease of 82% in the num-
ber of hiccup events. However, this medication had to be with-
drawn due to poorly tolerated side effects (Table 1), such as se-
vere dizziness.
During the 18th month after presentation, omeprazole was 
changed to rabeprazole, which has a faster onset time. This lead 
to a very positive outcome because the hiccups occurred only 3 
times per week (reported in Table 1 as 0.42 on average).
In view of the lack of a total response to the medications, an 
intraluminal impedance pH-metry was performed during the Andrés de Hoyos, et al
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19th month without the use of PPIs; this was done to rule out 
non-acid reflux episodes and confirm the application of an appro-
priate treatment (Fig. 2). The results were as follows: 17 hiccups; 
35 reflux episodes, 24 of which were reported as acid reflux and 
11 as non-acid reflux and 2.1% of the time at pH＜ 4. In this 
test, the acid events were better correlated with the hiccups with a 
SAP of 100% and an SI of 82%, which confirmed the diagnosis 
of acid reflux as the unique cause of the patient’s symptoms.
In the 20th month, the patient decided to change her treat-
ment from rabeprazole to omeprazole because of its lower cost.
After 2 years, the control of the hiccups had substantially im-
proved with the use of PPIs, and the patient only experienced 4 to 
5 hiccup events per day. To date, this strategy of maintenance 
dosage with PPIs has been effective; however, if there was a de-
cline in her condition, we would consider adding additional phar-
macological agents. If all pharmacological approaches fail, a final 
option would be fundoplication surgery.
As a complement to the screening, an esophageal manometry 
of the patient was performed using a Medtronic Poligraf without 
the use of PPIs and prokinetics. The patient displayed an effec-
tive esophageal motility with an amplitude pressure in the esoph-
ageal body ＞ 30 mmHg. Nevertheless, in the distal esophagus, 
a hypotensive lower esophageal sphincter resting pressure of only 
4.4 mmHg was registered.
Discussion
The present case illustrates that sometimes, when facing per-
sistent hiccups, we must rule out the presence of gastroesopha-
geal reflux disease, which may produce a recurrent stimulation of 
the arch reflex that is likely due to irritation of the neural termi-
nals connected to the gastro-esophageal mucosa. After other or-
ganic pathologies were ruled out by the work-up, the use of con-
ventional pH monitoring was able to establish a diagnosis of re-
flux disease as the cause of the hiccups.
7
Some features of our patient should be highlighted because 
she belongs to the non-erosive reflux disease (NERD) group 
with atypical symptoms.
8 Similar to our case, there is only a parti-
al response to pharmacological treatment in this population of pa-
tients, and it is accepted that a considerable percentage of this 
group (20%-30%) have a poor response to PPIs compared to 
those with erosive esophagitis.
9 On the other hand, these NERD 
patients, who have increased distal esophageal acid exposure, 
present a higher proportion of symptom resolution with PPI 
therapy; these characteristics correlate with the elevated acid ex-
posure and the good response to PPIs shown in this case.
10
An important parameter that indicates a good association be-
tween hiccups and reflux is the presence of a positive SAP.
11 This 
expresses the probability that the patient’s symptoms may be re-
lated to reflux and is calculated using the Fisher’s Test, which 
quantifies the probability that the observed distribution is not 
produced by chance; this guarantees that the result was not ob-
tained at random and therefore, achieves greater certainty.
12 On 
the contrary, the SI was negative but was very close to a positive 
result. This probably occurred because the SI does not take the 
total number of reflux episodes into account, and a symptom in-
dex might be associated with reflux by chance. Therefore, the nu-
merical result may be due to coincidence.
13
When a case of hiccups becomes persistent or intractable, it is 
likely to result from serious pathophysiological processes that af-
fect a component of the hiccup reflex mechanism. According to 
Martínez and Villamil,
3 in the hospitalized patients, the 2 most 
common etiologies of intractable hiccups are digestive tract dis-
orders (62.5%) and CNS diseases (33.3%). Medication use is an-
other frequent cause in patients with organic pathologies. Most 
persistent hiccups are associated with organic conditions and oc-
cur more frequently in men (≥ 82%).
14 However, our patient 
was female, and we did not discover any common organic patho-
logic causes. Although the literature contains reports of rare caus-
es of hiccups, the presence of NERD should always be consid-
ered if the work-up does not reveal a clear etiology because 
NERD treatment can offer a better outcome and prognosis.
Many drugs have been used to treat hiccups. Some of these 
have more specific uses and are intended to treat more specific 
causes. The most common initial drug for the treatment of chron-
ic hiccups is metoclopramide, which is useful because it blocks 
the dopamine receptors in the chemoreceptor trigger zone of the 
CNS.
15 Chlorpromazine and haloperidol also have antidopami-
nergic mechanisms of action
16 and are effective
17 at stopping in-
tractable hiccups.
Moreover, several anticonvulsant agents are used to treat in-
tractable hiccups. Phenytoin, valproic acid and carbamazepine 
can all be effective when used at typical anticonvulsant doses.
18 
Gabapentin has been shown to be more effective when CNS le-
sions are present or in other specialized situations.
Recently, baclofen has emerged as a safe and often effective 
treatment for protracted hiccups, and it results in a complete reso-
lution in up to 82% of cases. It is used to treat patients with an un-
known cause of hiccups or those who have failed to respond to 
treatment of a documented esophageal disease.
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In conclusion, after an extensive work-up of hiccups, if the 
symptoms seem to be secondary to NERD, we strongly recom-
mend starting treatment with PPIs at elevated doses. If it be-
comes necessary, addition of any of the other treatments de-
scribed in this report may also be beneficial.
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